Analysts expect Insight Molecular Diagnostics Inc. to report revenue of 225,982.06 for Q3 26, against a range of 218,435.39 to 233,528.73. The most recent reported quarter, Q2 26, came in at 239,000.00, a 29.0% miss against the 336,748.54 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 115,000.00 | 1.49 M | 2.14 M | 518,000.00 | 260,000.00 | 1.14 M | 32,000.00 | 239,000.00 | - | - | - | - | - | - | - | - | ||||||
| High Estimate | 206,078.35 | 116,903.70 | 138,797.96 | 309,661.44 | 292,638.64 | 300,725.93 | 250,121.58 | 351,487.69 | 233,528.73 | 475,178.25 | 398,071.76 | 889,082.06 | 921,174.60 | 2.69 M | 2.85 M | 6.80 M | ||||||
| Low Estimate | 170,736.51 | 100,377.30 | 126,674.88 | 290,232.66 | 239,665.34 | 250,843.13 | 230,117.24 | 322,009.39 | 218,435.39 | 411,163.13 | 356,724.04 | 774,988.40 | 768,223.28 | 2.36 M | 2.48 M | 6.31 M | ||||||
| Consensus Estimate | 188,407.43 | 108,640.50 | 132,736.42 | 299,947.05 | 266,151.99 | 275,784.53 | 240,119.41 | 336,748.54 | 225,982.06 | 443,170.69 | 377,397.90 | 832,035.23 | 844,698.94 | 2.53 M | 2.67 M | 6.56 M |
Analysts expect Insight Molecular Diagnostics Inc. to report earnings per share of -0.26 for Q3 26, against a range of -0.27 to -0.25. The most recent reported quarter, Q2 26, came in at -0.31, a 29.2% miss against the -0.24 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.40 | -1.93 | -0.26 | -0.30 | -0.34 | -0.72 | -0.12 | -0.31 | - | - | - | - | - | - | - | - | ||||||
| High Estimate | -0.40 | -0.34 | -0.24 | -0.20 | -0.20 | -0.23 | -0.23 | -0.23 | -0.25 | -0.20 | -0.20 | -0.18 | -0.19 | -0.29 | 0.02 | -0.13 | ||||||
| Low Estimate | -0.44 | -0.40 | -0.28 | -0.22 | -0.24 | -0.27 | -0.25 | -0.25 | -0.27 | -0.24 | -0.24 | -0.22 | -0.21 | -0.33 | 0.02 | -0.15 | ||||||
| Consensus Estimate | -0.42 | -0.37 | -0.26 | -0.21 | -0.22 | -0.25 | -0.24 | -0.24 | -0.26 | -0.22 | -0.22 | -0.20 | -0.20 | -0.31 | 0.02 | -0.14 |
Pull Wall Street consensus for Insight Molecular Diagnostics Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=IMDX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "IMDX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=IMDX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();